Xencor | XNCR - Current Liabilities

Stock Price
11.34
Daily Change
-0.07 -0.61%
Monthly
-12.90%
Yearly
-24.70%
Q1 Forecast
11.06

Xencor reported $86.48M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Arrowhead Research USD 347.42M 151.94M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cytokinetics USD 142.14M 11.08M Sep/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Xencor USD 86.48M 9.6M Sep/2025